The deep knowledge of NB tumor genetics and biology have allowed to establish effective treatments for some of NB patients, such as infants and children with localized, MYCN not amplified tumors, with 5-year survival rates between 90 and 100%, depending on age and stage [12]. Here, MYCN is linked to neuroblastoma.